NCT03060057View on ClinicalTrials.gov

"Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - U-Propel Study"

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2026

Conditions
Osteo Arthritis Knee
Interventions
DEVICE

U2 Knee™ System

The United U2 Knee™ System consists of several components and for this clinical evaluation it includes the (1) Femoral Component, (2) Tibial Insert, 3) Tibial Baseplate, and the 4) Patella.

Trial Locations (4)

21215

Rubin Institute for Advanced Orthopedics, Baltimore

32204

Jacksonville Orthopaedic Institute, Jacksonville

32960

Orthopedic Center of Vero Beach, Vero Beach

34209

Coastal Orthopedics, Bradenton

All Listed Sponsors
lead

United Orthopedic Corporation

INDUSTRY

NCT03060057 - "Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - U-Propel Study" | Biotech Hunter | Biotech Hunter